Citi downgrades Mednax, Inc (NYSE: MD) from Buy to Hold. Price target lowered from $53 to $37.

Citi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE